These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24135743)

  • 1. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.
    Thaivalappil S; Bauman N; Saieg A; Movius E; Brown KJ; Preciado D
    JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1026-31. PubMed ID: 24135743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial.
    Bauman NM; McCarter RJ; Guzzetta PC; Shin JJ; Oh AK; Preciado DA; He J; Greene EA; Puttgen KB
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):323-30. PubMed ID: 24526257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of oral propranolol on urine bFGF, MMP-2, MMP-9 expression in children with proliferative infantile hemangioma].
    Yuan WL; Wang XK
    Shanghai Kou Qiang Yi Xue; 2022 Aug; 31(4):400-405. PubMed ID: 36710554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study.
    Malik MA; Menon P; Rao KL; Samujh R
    J Pediatr Surg; 2013 Dec; 48(12):2453-9. PubMed ID: 24314186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy.
    Kleber CJ; Spiess A; Kleber JB; Hinz U; Holland-Cunz S; Weiss J
    Eur J Pediatr; 2012 Jun; 171(6):941-6. PubMed ID: 22203431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue and serum mRNA profile of MMPs-2/9 as a potential novel biomarker for the most individual approach in infantile hemangiomas and cancer disease.
    Taran K; Wnęk A; Kobos J; Andrzejewska E; Przewratil P
    Immunobiology; 2017 Nov; 222(11):1035-1042. PubMed ID: 28601470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of infantile hemangiomas-experience of a tertiary hospital.
    Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
    Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).
    Chu DH; Castelo-Soccio L; Wan J; Gelfand JM; Shaddy RE; Shah KN; Perman MJ; Treat JR; Yan AC
    Clin Pediatr (Phila); 2014 Oct; 53(11):1084-90. PubMed ID: 24849505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined low-dose oral propranolol and oral prednisolone as first-line treatment in periocular infantile hemangiomas.
    Koay AC; Choo MM; Nathan AM; Omar A; Lim CT
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):309-11. PubMed ID: 21542771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
    Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
    Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
    Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
    JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
    López-Gutiérrez JC
    Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
    MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
    J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol and infantile hemangiomas four years later: a systematic review.
    Marqueling AL; Oza V; Frieden IJ; Puttgen KB
    Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propranolol in infantile hemangiomas].
    Léauté-Labrèze C
    Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
    Phillips JD; Zhang H; Wei T; Richter GT
    JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.